 | • レポートコード：MRC2212E065 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、227ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートによると、世界の新生児集中治療用呼吸装置市場規模は、2021年に1,686.97百万ドル、2022年に1,910.92百万ドルと推定され、今後は年平均13.45％成長して2027年までに3,597.39百万ドルに達するとみられています。当書では、新生児集中治療用呼吸装置の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、デバイス種類別（無呼吸モニター、持続気道陽圧装置、吸入器、ネブライザー、人工呼吸器）分析、エンドユーザー別（NICU病院、介護施設、個人、専門クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめています。なお、当書に掲載されている企業情報には、3B Medical, Inc.、ACUTRONIC Medical Systems、AeroCare Holdings、Atlantamed、Atom Medical Corporation、AVI Healthcare、Becton, Dickinson & Company、Beijing Eternity Electronic Technology Co., Ltd.、Bio-Med Devices、BMC Medical Co., Ltd.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の新生児集中治療用呼吸装置市場規模：デバイス種類別 - 無呼吸モニターの市場規模 - 持続気道陽圧装置の市場規模 - 吸入器の市場規模 - ネブライザーの市場規模 - 人工呼吸器の市場規模 ・世界の新生児集中治療用呼吸装置市場規模：エンドユーザー別 - NICU病院における市場規模 - 介護施設における市場規模 - 個人における市場規模 - 専門クリニックにおける市場規模 ・世界の新生児集中治療用呼吸装置市場規模：地域別 - 南北アメリカの新生児集中治療用呼吸装置市場規模 アメリカの新生児集中治療用呼吸装置市場規模 カナダの新生児集中治療用呼吸装置市場規模 ブラジルの新生児集中治療用呼吸装置市場規模 ... - アジア太平洋の新生児集中治療用呼吸装置市場規模 日本の新生児集中治療用呼吸装置市場規模 中国の新生児集中治療用呼吸装置市場規模 インドの新生児集中治療用呼吸装置市場規模 韓国の新生児集中治療用呼吸装置市場規模 台湾の新生児集中治療用呼吸装置市場規模 ... - ヨーロッパ/中東/アフリカの新生児集中治療用呼吸装置市場規模 イギリスの新生児集中治療用呼吸装置市場規模 ドイツの新生児集中治療用呼吸装置市場規模 フランスの新生児集中治療用呼吸装置市場規模 ロシアの新生児集中治療用呼吸装置市場規模 ... - その他地域の新生児集中治療用呼吸装置市場規模 ・競争状況 ・企業情報 |
The Global Neonatal Intensive Care Respiratory Devices Market size was estimated at USD 1,686.97 million in 2021 and expected to reach USD 1,910.92 million in 2022, and is projected to grow at a CAGR 13.45% to reach USD 3,597.39 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Neonatal Intensive Care Respiratory Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Device Type, the market was studied across Apnea Monitors, Continuous Positive Airway Pressure Devices, Inhalers, Nebulizers, and Ventilators.
Based on End-User, the market was studied across NICU Hospitals, Nursing Homes, Personal User, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Neonatal Intensive Care Respiratory Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neonatal Intensive Care Respiratory Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neonatal Intensive Care Respiratory Devices Market, including 3B Medical, Inc., ACUTRONIC Medical Systems, AeroCare Holdings, Atlantamed, Atom Medical Corporation, AVI Healthcare, Becton, Dickinson & Company, Beijing Eternity Electronic Technology Co., Ltd., Bio-Med Devices, BMC Medical Co., Ltd., Braebon Medical Corporation, Comen, Drive DeVilbiss Healthcare, Inc., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, FRESCA Medical, GaleMed Corporation, GE Healthcare, Getinge AB, Hamilton Medical, Inspiration Healthcare Group plc, Invacare Corporation, Medtronic plc, Mercury Medical, Microchip Technology Inc., Resmed, SLE, Smiths Medical, SomnoMed, Teleflex Incorporated, Texas Instruments Incorporated, Trudell Medical International, and VYAIRE MEDICAL, INC.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neonatal Intensive Care Respiratory Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neonatal Intensive Care Respiratory Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neonatal Intensive Care Respiratory Devices Market?
4. What is the competitive strategic window for opportunities in the Global Neonatal Intensive Care Respiratory Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Neonatal Intensive Care Respiratory Devices Market?
6. What is the market share of the leading vendors in the Global Neonatal Intensive Care Respiratory Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Neonatal Intensive Care Respiratory Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the number of preterm births
5.1.1.2. Growing number of respiratory diseases in newborn babies
5.1.1.3. Favorable government investments to enhance healthcare infrastructure
5.1.2. Restraints
5.1.2.1. Reduced adoption of advanced respiratory care devices in under-developed and developing economies
5.1.3. Opportunities
5.1.3.1. Emerging strategic partnership to expand in the developing economies
5.1.3.2. Proliferation in research and development activities with immense investments
5.1.4. Challenges
5.1.4.1. High cost of neonatal respiratory care devices
5.2. Cumulative Impact of COVID-19
6. Neonatal Intensive Care Respiratory Devices Market, by Device Type
6.1. Introduction
6.2. Apnea Monitors
6.3. Continuous Positive Airway Pressure Devices
6.4. Inhalers
6.5. Nebulizers
6.6. Ventilators
7. Neonatal Intensive Care Respiratory Devices Market, by End-User
7.1. Introduction
7.2. NICU Hospitals
7.3. Nursing Homes
7.4. Personal User
7.5. Specialty Clinics
8. Americas Neonatal Intensive Care Respiratory Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Neonatal Intensive Care Respiratory Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Neonatal Intensive Care Respiratory Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. 3B Medical, Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. ACUTRONIC Medical Systems
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. AeroCare Holdings
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Atlantamed
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Atom Medical Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. AVI Healthcare
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Becton, Dickinson & Company
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Beijing Eternity Electronic Technology Co., Ltd.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Bio-Med Devices
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. BMC Medical Co., Ltd.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Braebon Medical Corporation
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Comen
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Drive DeVilbiss Healthcare, Inc.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Drägerwerk AG & Co. KGaA
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Fisher & Paykel Healthcare Limited
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. FRESCA Medical
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. GaleMed Corporation
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. GE Healthcare
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Getinge AB
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Hamilton Medical
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Inspiration Healthcare Group plc
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Invacare Corporation
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Medtronic plc
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. Mercury Medical
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services
12.25. Microchip Technology Inc.
12.25.1. Business Overview
12.25.2. Key Executives
12.25.3. Product & Services
12.26. Resmed
12.26.1. Business Overview
12.26.2. Key Executives
12.26.3. Product & Services
12.27. SLE
12.27.1. Business Overview
12.27.2. Key Executives
12.27.3. Product & Services
12.28. Smiths Medical
12.28.1. Business Overview
12.28.2. Key Executives
12.28.3. Product & Services
12.29. SomnoMed
12.29.1. Business Overview
12.29.2. Key Executives
12.29.3. Product & Services
12.30. Teleflex Incorporated
12.30.1. Business Overview
12.30.2. Key Executives
12.30.3. Product & Services
12.31. Texas Instruments Incorporated
12.31.1. Business Overview
12.31.2. Key Executives
12.31.3. Product & Services
12.32. Trudell Medical International
12.32.1. Business Overview
12.32.2. Key Executives
12.32.3. Product & Services
12.33. VYAIRE MEDICAL, INC
12.33.1. Business Overview
12.33.2. Key Executives
12.33.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing